2024 Pediatric Oncology Integrative Diagnostics and Targeted Therapies Symposium

November 7, 2024 - November 9, 2024
Adolescent child sitting up in a hospital bed being seen by a physician

This hybrid symposium, sponsored by the Nationwide Children’s Hospital Division of Hematology, Oncology, and Blood & Marrow Transplant, in collaboration with Department of Pathology and the Institute for Genomic Medicine, will provide a comprehensive 3-day overview of current and developing diagnostic and therapeutic approaches, allowing pediatric oncology teams to integrate these new tools at each stage of care of children with cancer.

Learn More

Intended Audience

This conference is designed for physicians and researchers at all levels of training, nurse practitioners, pharmacists, nursing, psychosocial services, and other members of patient care teams.

Topics Will Include: 


Day 1 Sessions Day 2 and 3 Sessions
Topics
  • Best sampling approaches
  • Role of Conventional Histopathology
  • Molecular Diagnostics
  • Next-generation Sequencing and Developing Methods
  • Roles of Genetic Counseling
  • Mock Tumor Boards to Demonstrate Best Practices
  • Biologic Therapies
  • Cellular Therapies
  • Small Molecule Drugs
  • New Classes of Agents
  • Application to Pediatric Leukemia
  • Lymphomas and Solid Tumors
  • Management and Practical Application of Therapies
  • Parental and Family Concerns in Treatment